Development and Optimization of Technetium-99m Radiolabeled Chitosan Nanoparticles for Potential Theranostic Applications in Cancer
Indonesian Journal of Pharmacy · 06.05.2026 · 287-298
DOI: 10.22146/ijp.16994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 06.05.2026. Verfasst von Amir Firdaus Abdul Aziz und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).
Abstract (Originalsprache)
The appealing physical properties of 99mTc, such as its 6-hour half-life, emission of 140 keV gamma rays, and availability from affordable generators, have made its application preferable in SPECT imaging. The labelling of certain targeting moieties such as nanoparticles with 99mTc could improve the detection of diseased tissues for enhanced diagnosis and therapies. Chitosan nanoparticles which possess many appealing properties like biocompatibility and biodegradability, have been the focus of many scientific studies, demonstrating its use in various applications. In this study, chitosan nanoparticles were developed using the ionic gelation method, and the effect of concentration and pH of the medium on the size of the nanoparticles were evaluated. The nanoparticles produced were radiolabelled with 99mTc, which has a radioactivity range of between 100–111 MBq (2.7–3 mCi), and the stability of the radiolabelling was evaluated. The nanoparticles were found to be in the nanometres range, between 81 to 270 nm. The labeling efficiency of the 99mTc-labeled chitosan nanoparticles was determined to be higher than 90%, with more than 6 hours of stability. In conclusion, the 99mTc-radiolabelled chitosan-based radiopharmaceutical has shown good and promising characteristics and may be potentially useful as a dual-function theranostic agent in the future.
Zitieren
APA
Aziz, A. F. A., Hamzah, F., Muchtaridi, M., & Gazzali, A. M. (2026). Development and Optimization of Technetium-99m Radiolabeled Chitosan Nanoparticles for Potential Theranostic Applications in Cancer. Indonesian Journal of Pharmacy, 287-298. https://doi.org/10.22146/ijp.16994
Vancouver
Aziz AFA, Hamzah F, Muchtaridi M, Gazzali AM. Development and Optimization of Technetium-99m Radiolabeled Chitosan Nanoparticles for Potential Theranostic Applications in Cancer. Indonesian Journal of Pharmacy. 2026:287-298. doi:10.22146/ijp.16994
BibTeX
@article{Aziz2026,
author = {Aziz, Amir Firdaus Abdul and Hamzah, Fadzilah and Muchtaridi, Muchtaridi and Gazzali, Amirah Mohd},
title = {Development and Optimization of Technetium-99m Radiolabeled Chitosan Nanoparticles for Potential Theranostic Applications in Cancer},
journal = {Indonesian Journal of Pharmacy},
year = {2026},
pages = {287--298},
doi = {10.22146/ijp.16994}
}
EUVIMED